AZN vs GDRX · P/E 28, $288.38B cap vs P/E 49, rev $394.4M
AstraZeneca PLC (AZN) versus Goodrx Holdings Inc (GDRX) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Goodrx Holdings Inc (GDRX) is a health information services company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported GDRX revenue for 2026-06-30 was $394.4M. Net income was $9.7M. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
Not investment advice. Open the AZN and GDRX stock pages for the full models.
Not investment advice.